Instalab

Paper Mulberry IgE Test Blood

See whether paper mulberry pollen is the hidden trigger behind your seasonal allergy symptoms.

Should you take a Paper Mulberry IgE test?

This test is most useful if any of these apply to you.

Hit Hard by Spring Allergies
You get hay fever or congestion in late winter or early spring and want to know whether tree pollen, specifically paper mulberry, is the trigger.
Asthma That Flares Seasonally
Your asthma gets harder to control during specific months and you want to identify which airborne allergens are pushing it over the edge.
Living in a High-Exposure Region
You live in or recently moved from areas where paper mulberry is abundant, like Southwest China, Pakistan, or parts of the southern US.
Standard Allergy Panel Came Back Empty
You have clear allergy symptoms but a routine panel did not find a trigger, and you want to test a less commonly screened pollen.

About Paper Mulberry IgE

If you live in a region where paper mulberry trees grow heavily, your spring allergies may not be coming from the usual suspects. Paper mulberry pollen is one of the dominant airborne pollens in places like Southwest China and Islamabad, where it has been linked to allergic rhinitis and asthma exacerbations during peak season.

This test checks whether your immune system has produced antibodies specifically against paper mulberry pollen. A positive result tells you the tree is a likely contributor to your symptoms, which can shape decisions about avoidance, medication timing, and whether allergen-specific immunotherapy might be worth considering.

What This Test Actually Measures

The test measures IgE (immunoglobulin E) in your blood that specifically binds to proteins from paper mulberry (Broussonetia papyrifera) pollen. IgE is a type of antibody your immune system makes after it has decided a harmless substance is a threat. When that antibody coats immune cells called mast cells and basophils, the next encounter with the pollen triggers them to release histamine and other chemicals, producing the runny nose, itchy eyes, congestion, and wheezing of an allergic reaction.

A positive result means your immune system is sensitized to paper mulberry. Sensitization is not the same as a clinical allergy. Many people have detectable IgE to allergens without ever developing symptoms. In a study of 1,000 healthy Japanese adults, 78% had IgE to at least one inhaled allergen, and in a study of 501 Austrian adolescents, more than half had IgE to at least one molecule. The test result becomes most meaningful when it matches a real-world pattern of symptoms during paper mulberry pollen season.

Why Paper Mulberry Matters as an Allergen

Paper mulberry is not just background pollen. In Southwest China, it accounted for 58.6% of total pollen grains measured throughout the year and has been identified as a significant cause of allergic rhinitis. In Islamabad, where the tree was planted heavily decades ago, an observational study of 324 people found that high paper mulberry pollen concentrations were associated with asthma exacerbations during peak season.

If you have unexplained respiratory symptoms in late winter or early spring and you live in or have traveled through a paper mulberry-heavy region, this test can help connect the dots. Standard allergy panels often focus on grasses, birch, ragweed, and dust mites, so paper mulberry sensitization can be missed unless someone specifically looks for it.

Allergic Rhinitis and Asthma

The strongest clinical link for paper mulberry pollen is with seasonal allergic rhinitis (hay fever) and asthma flares. In the Islamabad study, asthma exacerbations rose with high pollen counts, suggesting that for sensitized people, the tree can push borderline-controlled asthma into clinical trouble.

This pattern mirrors what is known about allergen-specific IgE more broadly. Across population studies, higher specific IgE to pollens is consistently associated with allergic rhinitis severity, asthma symptoms, and poorer quality of life. In a study of 1,476 school-aged children in Japan, high specific IgE to local pollen was linked to moderate-to-severe rhinitis symptoms and worse quality-of-life scores. A separate cohort of 8,629 people with allergic rhinitis found that higher specific IgE corresponded to more severe symptoms, while levels naturally decline with age, easing symptoms in older adults.

Cross-Reactivity With Birch and Related Trees

Paper mulberry pollen can also trip up your immune system through cross-reactivity, where antibodies built against one allergen react to similar-looking proteins in another. A case report describing systemic allergic reactions to mulberry fruit found that the patient's blood contained IgE that bound a roughly 17 kilodalton protein band (a measure of protein size), suggested to belong to a family called PR-10 proteins. PR-10 proteins are also found in birch pollen, hazelnut, apple, and many other plants, and are a common source of cross-reactive allergy.

What this means for you: if you test positive for paper mulberry IgE but also react to birch or to certain raw fruits, the pattern may reflect a shared protein family rather than independent allergies. A specialist can help untangle which exposure is the real driver of your symptoms.

Sensitization Is Not the Same as Allergy

This distinction matters enough to call out separately. A positive paper mulberry IgE result tells you that your immune system has built antibodies against the pollen. It does not by itself tell you that you will react when exposed. Across multiple population studies, large fractions of healthy adults have positive specific IgE results without symptoms.

Conversely, a negative or low result does not fully rule allergy out. Some people with clear allergic symptoms have normal total IgE or undetectable specific IgE. The test is most useful when combined with your symptom history and, when needed, skin prick testing or a specialist's clinical assessment.

Tracking Your Trend

A single IgE value is a snapshot, not a fixed trait. Levels of specific IgE shift with ongoing exposure, age, and treatment. Allergen-specific IgE generally declines with age, which is why older adults often report milder seasonal symptoms than they had in their thirties. If you start allergen-specific immunotherapy, your treating clinician will typically watch specific IgE alongside other markers; immunotherapy can lower allergen-specific IgE over months while raising blocking IgG4 antibodies that calm the allergic response.

A reasonable approach for someone managing seasonal symptoms is to get a baseline test, retest in 6 to 12 months if you start immunotherapy or change exposure significantly (for example, by moving regions), and then check every 1 to 2 years to track trajectory. The trend over time is more informative than any single number, especially for an emerging marker without standardized clinical cutoffs.

When Results Can Be Misleading

A few factors can blur the interpretation of a single reading. Knowing them helps you decide whether your result truly reflects your immune state.

  • Cross-reactive carbohydrate determinants (CCDs): sugar groups on plant and insect proteins that can trigger IgE binding in the lab without causing real-world symptoms, producing falsely positive pollen and food IgE results. Specialty CCD inhibition testing can clarify which results reflect genuine sensitization.
  • Recent immunotherapy or anti-IgE biologics: treatments like omalizumab and ongoing allergen immunotherapy actively change IgE biology. Dupilumab has been shown to significantly reduce total IgE levels, which can shift interpretation of specific IgE results.
  • High total IgE from unrelated causes: parasitic infection, atopic dermatitis, or certain immune disorders can elevate background IgE and affect how individual specific IgE results are interpreted.
  • Sensitization without exposure history: a positive result in someone with no recognizable paper mulberry exposure may reflect cross-reactivity with another tree pollen rather than true paper mulberry allergy.

What to Do With an Unexpected Result

If your paper mulberry IgE comes back positive and your symptoms fit a seasonal pattern, the next steps are clinical, not numerical. A consultation with an allergist can confirm whether the result matches your symptom timeline, rule out cross-reactivity with birch or other tree pollens using component-resolved testing, and discuss whether avoidance, pre-season antihistamines or nasal steroids, or allergen-specific immunotherapy makes sense for you.

If the result is positive but you have no symptoms, no immediate action is needed. Treat it as useful background information: you have a sensitization that could become clinically relevant if your exposure increases, for example through a move or a change in local plantings. If the result is negative but your symptoms strongly suggest pollen allergy, a broader panel of tree, grass, and weed allergens, plus skin prick testing, can help find the real trigger.

What Moves This Biomarker

Evidence-backed interventions that affect your Paper Mulberry IgE level

Decrease
Omalizumab (anti-IgE biologic) combined with allergen immunotherapy
Omalizumab neutralizes circulating IgE, reducing how much is available to bind mast cells and basophils and changing the functional IgE response. In a randomized trial of 221 children and adolescents with seasonal allergic rhinitis, combining omalizumab with allergen immunotherapy reduced symptom load by 48% versus immunotherapy alone over two pollen seasons. In ragweed allergic rhinitis, the combination produced complete inhibition of IgE-allergen binding, with effects lasting up to 30 to 42 weeks after treatment stopped. Evidence is from grass, birch, and ragweed allergy, not paper mulberry specifically.
MedicationStrong Evidence
Decrease
Allergen-specific immunotherapy (subcutaneous or sublingual)
Immunotherapy is the only treatment proven to change the underlying biology of allergic sensitization rather than just mask symptoms. Over months to years, it lowers allergen-specific IgE in the nose and blood while raising protective blocking IgG4 antibodies and regulatory immune cells. In a trial of 35 adults with allergic rhinitis treated with grass pollen subcutaneous immunotherapy, nasal IgG-associated inhibitory activity rose to about 93% (and 66% in serum), closely matching symptom improvement. Evidence comes from grass, birch, and ragweed immunotherapy; the effect on paper mulberry IgE specifically has not been measured.
MedicationModerate Evidence
Decrease
Dupilumab (anti-IL-4/IL-13 biologic)
Dupilumab blocks signaling that drives IgE class switching, significantly reducing total serum IgE over months of treatment in patients with allergic rhinitis and other type-2 inflammatory diseases. The effect on individual allergen-specific IgE results, including paper mulberry, has not been directly quantified. While total IgE drops, skin prick testing remains a reliable tool for detecting underlying sensitizations.
MedicationModerate Evidence

Frequently Asked Questions

References

15 studies
  1. Jiang Z, Xiao H, Zhang H, Jia Q, Lin H, Zhang L, Lidholm J, Borres M, Meng J, Wang LClinical & Experimental Allergy2022
  2. Yusuf O, Rextin a, Ahmed B, Aman R, Anjum T, Mustafa S, Nasim M, Yusuf S, Lin C, Zahra S, Pinnock H, Schwarze JJournal of Global Health2023
  3. Choi J, Sim J, Oh JY, Hur G, Min K, Lee S, Shim J, Kang KAllergy, Asthma & Immunology Research2014
  4. Ciprandi G, Comite P, Ferrero F, Fontana V, Bruzzone M, Mussap MRhinology2017
  5. Tanaka J, Fukutomi Y, Shiraishi Y, Kitahara a, Oguma T, Hamada Y, Watai K, Nagai T, Taniguchi M, Asano KAllergology International2021